Pharming PHAR
NASDAQ PHAR
$9.75 -0.23 (-2.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Price to FCF (2022 - 2026)

Updated

Pharming's (PHAR) Price to FCF came in at 63.08 for Q2 2026, down 92.1% from 795.68 a year earlier.

Analysis

Pharming (PHAR) Price to FCF (2022 - 2026) Analysis & Trends

For FY2025, Pharming's Price to FCF stood at 22.98.

  • In prior years, Pharming's Price to FCF was 30.37 in FY2022 (+154.4%) and 11.94 in FY2021 (-99.1%).
  • Quarterly Price to FCF has run from a low of 32.15 in Q4 2022 to a high of 795.68 in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Pharming 698.17 Mn -131.99 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.08
Dec 31, 2025 37.64
Jun 30, 2025 795.68
Dec 31, 2022 32.15
API Access

Pharming Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=PHAR&period=max&api_key=YOUR_API_KEY